Correlation Between Aerovate Therapeutics and Generative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Generative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Generative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Generative AI Solutions, you can compare the effects of market volatilities on Aerovate Therapeutics and Generative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Generative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Generative.

Diversification Opportunities for Aerovate Therapeutics and Generative

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Aerovate and Generative is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Generative AI Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Generative AI Solutions and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Generative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Generative AI Solutions has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Generative go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Generative

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Generative. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 8.9 times less risky than Generative. The stock trades about -0.02 of its potential returns per unit of risk. The Generative AI Solutions is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  8.00  in Generative AI Solutions on September 14, 2024 and sell it today you would lose (0.20) from holding Generative AI Solutions or give up 2.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Generative AI Solutions

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Generative AI Solutions 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Generative AI Solutions are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Generative reported solid returns over the last few months and may actually be approaching a breakup point.

Aerovate Therapeutics and Generative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Generative

The main advantage of trading using opposite Aerovate Therapeutics and Generative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Generative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generative will offset losses from the drop in Generative's long position.
The idea behind Aerovate Therapeutics and Generative AI Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account